MFTZ-1 reduces constitutive and inducible HIF-1 alpha accumulation and VEGF secretion independent of its topoisomerase II inhibition
Dai, Mei1; Miao, Ze-Hong1; Ren, Xuan1; Tong, Lin-Jiang1; Yang, Na1; Li, Ting1; Lin, Li-Ping1; Shen, Yue-Mao2; Ding, Jian1
2010-09-01
发表期刊JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
卷号14期号:9页码:2281-2291
摘要The macrolide compound MFTZ-1 has been identified as a novel topoisomerase II (Top2) inhibitor with potent in vitro and in vivo anti-tumour activities. In this study, we further examined the effects of MFTZ-1 on hypoxia-inducible factor-1 alpha (HIF-1 alpha) accumulation, vascular endothelial growth factor (VEGF) secretion and angiogenesis. MFTZ-1 reduced HIF-1 alpha accumulation driven by hypoxia or growth factors in human cancer cells. Mechanistic studies revealed that MFTZ-1 did not affect the degradation of HIF-1 alpha protein or the level of HIF-1 alpha mRNA. By contrast, MFTZ-1 apparently inhibited constitutive and inducible activation of both phosphatidylinositol-3-kinase (PI3K)-Akt and p42/p44 mitogen-activated protein kinase (MAPK) pathways. Further studies revealed that MFTZ-1 abrogated the HIF-1 alpha-driven increase in VEGF mRNA and protein secretion. MFTZ-1 also lowered the basal level of VEGF secretion. The results reveal an important feature that MFTZ-1 can reduce constitutive, HIF-1 alpha-independent VEGF secretion and concurrently antagonize inducible, HIF-1 alpha-dependent VEGF secretion. Moreover, MFTZ-1 disrupted tube formation of human umbilical vein endothelial cells (HUVECs) stimulated by hypoxia with low-concentration serum or by serum at normoxia, and inhibited HUVECs migration at normoxia. MFTZ-1 also prevented microvessel outgrowth from rat aortic ring. These data reflect the potent anti-angiogenesis of MFTZ-1 under different conditions. Furthermore, using specific small interfering RNA targeting Top2 alpha or Top2-defective HL60/MX2 cells, we showed that MFTZ-1 affected HIF-1 alpha accumulation and HUVECs tube formation irrelevant to its Top2 inhibition. Taken together, our data collectively reveal that MFTZ-1 reduces constitutive and inducible HIF-1 alpha accumulation and VEGF secretion possibly via PI3K-Akt and MAPK pathways, eliciting anti-angiogenesis independently of its Top2 inhibition.
关键词Mftz-1 Hif-1 Alpha Vegf Angiogenesis Topoisomerase Ii Inhibitor
DOI10.1111/j.1582-4934.2009.00822.x
收录类别SCI
语种英语
WOS记录号WOS:000282874000014
引用统计
文献类型期刊论文
条目标识符http://ir.kib.ac.cn/handle/151853/23915
专题植物化学与西部植物资源持续利用国家重点实验室
作者单位1.Chinese Acad Sci, Shanghai Inst Mat Med, Div Antitumor Pharmacol, State Key Lab Drug Res, Shanghai 201203, Peoples R China
2.Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resouces W China, Kunming, Peoples R China
推荐引用方式
GB/T 7714
Dai, Mei,Miao, Ze-Hong,Ren, Xuan,et al. MFTZ-1 reduces constitutive and inducible HIF-1 alpha accumulation and VEGF secretion independent of its topoisomerase II inhibition[J]. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE,2010,14(9):2281-2291.
APA Dai, Mei.,Miao, Ze-Hong.,Ren, Xuan.,Tong, Lin-Jiang.,Yang, Na.,...&Ding, Jian.(2010).MFTZ-1 reduces constitutive and inducible HIF-1 alpha accumulation and VEGF secretion independent of its topoisomerase II inhibition.JOURNAL OF CELLULAR AND MOLECULAR MEDICINE,14(9),2281-2291.
MLA Dai, Mei,et al."MFTZ-1 reduces constitutive and inducible HIF-1 alpha accumulation and VEGF secretion independent of its topoisomerase II inhibition".JOURNAL OF CELLULAR AND MOLECULAR MEDICINE 14.9(2010):2281-2291.
条目包含的文件 下载所有文件
文件名称/大小 文献类型 版本类型 开放类型 使用许可
dai2009.pdf(1133KB)期刊论文出版稿开放获取CC BY-NC-SA浏览 下载
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Dai, Mei]的文章
[Miao, Ze-Hong]的文章
[Ren, Xuan]的文章
百度学术
百度学术中相似的文章
[Dai, Mei]的文章
[Miao, Ze-Hong]的文章
[Ren, Xuan]的文章
必应学术
必应学术中相似的文章
[Dai, Mei]的文章
[Miao, Ze-Hong]的文章
[Ren, Xuan]的文章
相关权益政策
暂无数据
收藏/分享
文件名: dai2009.pdf
格式: Adobe PDF
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。